All Stories

  1. The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, September 2018, Dove Medical Press

    Dr Jeng-Yuan Hsu, Dr Yu-Feng Wei

  2. Long-acting beta2-agonists versus long-acting muscarinic antagonists in patients with stable COPD: A systematic review and meta-analysis of randomized controlled trials

    Article • Respirology, June 2017, Wiley

    Dr Yu-Feng Wei, Yung-Che Chen

  3. Scabies increased the risk and severity of COPD: a nationwide population-based study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, September 2016, Dove Medical Press

    Dr Yu-Feng Wei

  4. wheezing is a phenotype of COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, October 2015, Dove Medical Press

    Dr Yu-Feng Wei, Dr Jeng-Yuan Hsu, Dr Wan-Chun Huang

  5. Factors associated with the prescription of inhaled corticosteroids in GOLD group A and B patients with COPD – subgroup analysis of the Taiwan obstructive lung disease cohort

    Article • International Journal of Chronic Obstructive Pulmonary Disease, September 2015, Dove Medical Press

    Dr Yu-Feng Wei, Dr Jeng-Yuan Hsu